Hematological Adverse Events with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review with Meta-AnalysisOlivia Kronick, Cassie S. Mitchell, David Kartchner et al.|Cancers|2023Cited by 20